Skip to main content
新芝生物 logo

新芝生物 — Investor Relations & Filings

Ticker · 920685 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 390 across all filing types
Latest filing 2023-06-08 Capital/Financing Update
Country CN China
Listing Beijing Stock Exchange 920685

About 新芝生物

https://www.scientz.com/

Scientz Biotechnology specializes in the design and manufacture of high-performance life science instruments and laboratory equipment. The product range features ultrasonic cell disruptors, freeze dryers, gene guns, and high-pressure homogenizers, which are essential for sample preparation, cell lysis, and genetic engineering. The company also provides specialized solutions for tissue grinding, ultrasonic cleaning, and precise temperature control. These instruments serve a broad spectrum of applications in molecular biology, pharmaceutical research, environmental science, and agricultural technology. By integrating advanced ultrasonic and cryogenic technologies, Scientz supports research institutions and industrial laboratories in achieving accurate and reproducible results across various scientific disciplines.

Recent filings

Filing Released Lang Actions
关于使用部分闲置募集资金进行现金管理的进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from Ningbo New Gen Bio-tech Co., Ltd. regarding the progress of using part of idle raised funds for cash management. It details the authorization, types of financial products used, amounts, expected yields, risk controls, and internal oversight related to the use of idle raised funds. The document references board and shareholder meeting resolutions approving the use of idle raised funds for cash management. It does not contain comprehensive financial statements or detailed financial performance data. The document length is 4267 characters, which is relatively short and focused on a specific financing/capital management activity rather than a full financial report. This fits the category of Capital/Financing Update (CAP), as it provides updates on the company's use of raised funds and cash management activities.
2023-06-08 Chinese
首次回购股份暨回购进展情况公告
Transaction in Own Shares Classification · 100% confidence The document is an announcement regarding the company's share repurchase plan and the progress of the repurchase. It details the purpose, method, price, quantity, funding source, and timeline of the share buyback, as well as the actual shares repurchased to date. There is no financial statement or comprehensive report content, but rather an update on capital activity related to the company's own shares. This fits the definition of a Transaction in Own Shares (POS) filing, which covers share repurchase announcements and progress updates.
2023-06-07 Chinese
回购进展情况公告
Transaction in Own Shares Classification · 95% confidence The document is titled as a "回购进展情况公告" which translates to "Repurchase Progress Announcement." It details the company's share repurchase plan, including the purpose, method, price, quantity, funding source, implementation period, and progress as of a certain date. The document does not contain financial statements or detailed financial analysis but rather provides an update on the status of the share buyback program. This fits the description of a Transaction in Own Shares (POS) filing, which reports on the company's buyback or sale of its own shares. The document length is about 2009 characters, which is relatively short and focused on the repurchase update rather than a full financial report or announcement of a report publication. Therefore, the appropriate classification is POS with high confidence.
2023-06-01 Chinese
关于使用部分闲置募集资金进行现金管理的进展公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement regarding the company's use of idle raised funds for cash management, including specifics about authorized amounts, investment products, risk controls, and related board and shareholder meeting approvals. It includes tables of current and expired cash management products and references to relevant resolutions and agreements. The document is not a financial report like an annual or interim report, nor is it a simple announcement of a report publication. It is a regulatory disclosure about capital management activities related to raised funds, which fits best under Capital/Financing Update (CAP). The document length is 4291 characters, which is substantial for an announcement but does not contain financial statements or earnings data. Therefore, the classification is CAP with high confidence.
2023-05-24 Chinese
关于回购股份价格调整的提示性公告
Transaction in Own Shares Classification · 100% confidence The document is a public announcement from Ningbo New Century Biotechnology Co., Ltd. regarding an adjustment to the price limit for its share repurchase plan. It details the formula for adjusting the repurchase price, the basis for the adjustment related to the 2022 dividend distribution, and the new price limit effective from the ex-dividend date. The document does not contain financial statements or comprehensive financial data but focuses on the update about the share buyback price adjustment. This fits the category of a Transaction in Own Shares (POS) filing, which covers announcements about share repurchases or issuances.
2023-05-17 Chinese
2023年第一次职工代表大会决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolution passed at the company's first employee representative meeting in 2023. It details the meeting's convening, attendance, and the approval of a proposal to elect a new employee representative supervisor. There is no financial data, no mention of annual or interim reports, no audit information, no earnings release, and no regulatory filings related to financial performance. The content focuses on internal company governance matters, specifically the election of a board-related position (employee representative supervisor). This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board or senior management. The document is short and specific to a personnel change within the supervisory board, confirming the classification as MANG with high confidence.
2023-05-17 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.